نتایج جستجو برای: post marketing surveillance

تعداد نتایج: 538652  

Gholamreza Yarmohammadi Soghra Khabnadideh, Soliman Mohammadi Samani Zahra Rezaei,

       Propranolol, a prototypical b-adrenergic receptor antagonist and atenolol, a cardio-selective b-antagonist are widely used in therapeutic regimens for treatment of hypertensive patients. In Iran, several pharmaceutical manufacturers formulate these two b-blockers. As the formulation of a dosage form is essential for the patient's safety and drug efficacy, in this study we aimed to evalu...

Journal: :Pharmaceutical Regulatory Affairs: Open Access 2017

Journal: :Expert Review of Clinical Pharmacology 2016

Journal: :Indian journal of physiology and pharmacology 2012
Rajat Ray Meera Vaswani Koushik Sinha Deb Hem Sethi Anita Chopra Nand Kishore Rakesh Goyal

BACKGROUND & OBJECTIVES A combination of buprenorphine-naloxone (Addnok-N) tablets has been recently introduced in India as treatment for Opioid dependence. This study was undertaken to evaluate the possible adverse consequences following use of the buprenorphine-naloxone tablets through post marketing surveillance. METHODS National Drug Dependence Treatment Centre (NDDTC), AIIMS, India, moni...

Journal: :The International journal of risk & safety in medicine 1996
M J Staal

Neurosurgeons deal with the most vulnerable human organ, the central and peripheral nervous system (CNS and PNS): the brain and its efferent and afferent neural structures (spinal cord), and peripheral nerves. Also, the CNS blood vessel system as well as the CNS surrounding structures, like the membranes covering the CNS tissue and the bony elements enveloping the CNS (skull and spinal column),...

2015
Kazuki Maeda Rumi Katashima Keisuke Ishizawa Hiroaki Yanagawa

BACKGROUND Registration trials leading to the approval of drugs are paramount in drug development. After approval, continuous efforts are necessary to ensure proper use of the approved drugs. In Japan, post-marketing surveillance (PMS) by drug companies is conducted in accordance with good post-marketing study practice (GPSP). Although the global standard for pharmacovigilance is incorporated i...

Journal: :Drug safety 2016
Gregory E Powell Harry A Seifert Tjark Reblin Phil J Burstein James Blowers J Alan Menius Jeffery L Painter Michele Thomas Carrie E Pierce Harold W Rodriguez John S Brownstein Clark C Freifeld Heidi G Bell Nabarun Dasgupta

INTRODUCTION Post-marketing safety surveillance primarily relies on data from spontaneous adverse event reports, medical literature, and observational databases. Limitations of these data sources include potential under-reporting, lack of geographic diversity, and time lag between event occurrence and discovery. There is growing interest in exploring the use of social media ('social listening')...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید